Intrinsic Value of S&P & Nasdaq Contact Us
English English 中文(简) 中文(简) 中文(繁) 中文(繁) हिन्दी हिन्दी Español Español 日本語 日本語 한국어 한국어 Deutsch Deutsch Français Français
← Back to all stocks

BioPlus Acquisition Corp. BIOSW NASDAQ

NASDAQ Global Market • Financial Services • Shell Companies • US • USD

SharesGrow Score
58/100
2/5 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

BioPlus Acquisition Corp. (BIOSW) is a Shell Companies company in the Financial Services sector, currently trading at $0.00. It has a SharesGrow Score of 55/100, indicating a above average investment profile with 2 out of 7 criteria passed.

Net income is $5M, growing at +1124923.5%/yr. Net profit margin is 0% (thin). Gross margin is 34.3% (+1.3 pp trend).

Balance sheet: total debt is $5M against $223M equity (Debt-to-Equity (D/E) ratio 0.02, conservative). Current ratio is 1.04 (adequate). Debt-to-assets is 2.1%. Total assets: $238M.

SharesGrow 7-Criteria breakdown: Value 100/100 (Pass), Growth 58/100 (Partial), Past 25/100 (Fail), Health 75/100 (Pass), Moat 32/100 (Fail), Future ?/100 (Fail), Income ?/100 (Fail).

BIOSW SharesGrow Score Overview

58/100
SharesGrow Score
Above average fundamentals
View full scorecard →
VALUE 100/100
Valuation — P/E, PEG, Forward PEG
GROWTH 58/100
Financials — average growth
PAST 25/100
strong — trend
HEALTH 75/100
Balance sheet — Debt-to-Equity (D/E) ratio, Current ratio is
MOAT 32/100
Gross margin is + market cap
FUTURE 0/100
Analyst outlook — as buy
INCOME 0/100
Net profit margin is
Scores derived from financial statements, analyst ratings, and balance sheet data.

Score Breakdown — BIOSW

✓
VALUE Pass
100/100
BIOSW trades at a trailing Price-to-Earnings (P/E) of N/A (S&P 500 average ~25). Composite: Price-to-Earnings (20%) + Forward Price/Earnings-to-Growth (35%) + upside (25%) + trailing PEG (20%). ≥ 60 = Pass.
View details →
~
GROWTH Partial
58/100
BIOSW: -56.6%/yr revenue is, +1124923.5%/yr Net income is average growth. mixed. Score: >20%/yr = 100, >10% = 80, >5% = 65, >0% = 45, < 0 = 15.
View details →
✗
PAST Fail
25/100
BIOSW: 1 / 4 years profitable. weak. Score = 1 / 4 × 100. ≥ 80 = Pass.
View details →
✓
HEALTH Pass
75/100
Balance sheet BIOSW: Debt-to-Equity (D/E) ratio 0.02 (conservative), Current ratio is 1.04 (adequate). Debt-to-Equity < 0.5, Current Ratio > 1.5, Interest Coverage > 8x = ideal. ≥ 70 = Pass.
View details →
✗
MOAT Fail
32/100
BIOSW: Gross margin is 34.3% (+1.3 pp trend), N/A market cap. Moat (0-100): margin (35%) + trend (15%) + market cap (30%) + revenue is (20%). Score 32/100. ≥ 70 = Pass.
View details →
—
FUTURE N/A
N/A
No analyst coverage available for this stock.
—
INCOME N/A
N/A
No analyst coverage available for this stock.

Stock Chart & Stats

Market Data
52-Week Range8.0E-4-0.0028
Volume398.99K
Market Cap$209.07M
Beta (1Y)0.00
Share Statistics
EPS (TTM)0.01
Shares Outstanding$597.79M
IPO Date2022-01-24
CEOJonathan M. N. Rigby MBA
Financial Highlights & Ratios
Gross Profit$-1.17M
EBITDA$-1.17M
Net Income$5.16M
Operating Income$-1.17M
Total Cash$140.3K
Total Debt$5M
Net Debt$4.86M
Total Assets$238.32M
Price / Earnings (P/E)0.2
Analyst Forecast
Company Info
CountryUS
ExchangeNASDAQ Global Market
CurrencyUSD

Price Chart

Track all markets on TradingView
BIOSW
BioPlus Acquisition Corp. ↗  ·  NASDAQ Global Market
Financial Services • Shell Companies

People Also View

BRKHW
BRKHW
Burtech Acquisition Corp.
$0.60
+36.36%
 FRBNW
FRBNW
Forbion European Acquisition Corp.
$0.74
-9.76%
 HCMAW
HCMAW
HCM Acquisition Corp
$0.09
+108.33%
 BLEUW
BLEUW
bleuacacia ltd
$0.01
+592.86%
 CBRGW
CBRGW
Chain Bridge I
$0.05
+10.87%
 VITSX
VITSX
Vanguard Total Stock Market Index Fund Institutional Shares
$166.82
+1.15%
 VTSAX
VTSAX
Vanguard Total Stock Market Index Fund Admiral Shares
$166.79
+1.15%
 VSMPX
VSMPX
Vanguard Total Stock Market Index Fund Institutional Plus Shares
$312.93
+1.15%
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
📧 [email protected]
📞 +65 8912 8000
Send us a message